Literature DB >> 1819705

Production of platelet-activating factor by human normodense and hypodense eosinophils.

A Ojima-Uchiyama1, Y Masuzawa, T Sugiura, K Waku, T Fukuda, S Makino.   

Abstract

Normodense eosinophils and neutrophils from normal donors produced considerable amounts of platelet-activating factor (PAF) when stimulated with ionophore A23187. PAF produced by eosinophils appeared to be degraded more rapidly than PAF formed by neutrophils, suggesting a higher activity of PAF-degrading enzyme in eosinophils. Substantial proportions of PAF newly formed by both eosinophils and neutrophils were shown to be cell-associated. By comparison, hypodense eosinophils obtained from a patient with idiopathic hypereosinophilic syndrome produced an extremely large amount of PAF and released much of it into the incubation medium. The accelerated formation of PAF in hypodense eosinophils may be related to various cardiovascular complications associated with hypereosinophilic syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819705     DOI: 10.1007/BF02536531

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  34 in total

1.  Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis.

Authors:  K M Leiferman; S J Ackerman; H A Sampson; H S Haugen; P Y Venencie; G J Gleich
Journal:  N Engl J Med       Date:  1985-08-01       Impact factor: 91.245

Review 2.  Immunobiology of eosinophils.

Authors:  G J Gleich; D A Loegering
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

3.  Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.

Authors:  J H Sisson; S M Prescott; T M McIntyre; G A Zimmerman
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

4.  Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs.

Authors:  A Lellouch-Tubiana; J Lefort; E Pirotzky; B B Vargaftig; A Pfister
Journal:  Br J Exp Pathol       Date:  1985-06

5.  Increased biosynthesis of platelet-activating factor in activated human eosinophils.

Authors:  T Lee; D J Lenihan; B Malone; L L Roddy; S I Wasserman
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

6.  Preferential generation of leukotriene C4 by human eosinophils.

Authors:  R J Shaw; O Cromwell; A B Kay
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

7.  Leukotriene C4 production by normal-density and low-density eosinophils of atopic individuals and other patients with eosinophilia.

Authors:  H F Kauffman; B van der Belt; J G de Monchy; H Boelens; G H Koëter; K de Vries
Journal:  J Allergy Clin Immunol       Date:  1987-04       Impact factor: 10.793

8.  Metabolism of 1-O-alkyl-2-acetyl-sn-glycerol by washed rabbit platelets: formation of platelet activating factor.

Authors:  K Satouchi; M Oda; K Saito; D J Hanahan
Journal:  Arch Biochem Biophys       Date:  1984-10       Impact factor: 4.013

9.  Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.

Authors:  A Lellouch-Tubiana; J Lefort; M T Simon; A Pfister; B B Vargaftig
Journal:  Am Rev Respir Dis       Date:  1988-04

10.  Role of IgE receptors in effector function of human eosinophils.

Authors:  M Capron; H L Spiegelberg; L Prin; H Bennich; A E Butterworth; R J Pierce; M A Ouaissi; A Capron
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

View more
  4 in total

1.  Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis.

Authors:  Massimo Cugno; Angelo V Marzano; Maurizio Lorini; Vincenzo Carbonelli; Alberto Tedeschi
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

2.  Portal vein thrombosis and food protein-induced allergic proctocolitis in a premature newborn with hypereosinophilia: a case report.

Authors:  Cheong-Jun Moon; Tae Hee Kwon; Hyun-Seung Lee
Journal:  BMC Pediatr       Date:  2021-01-23       Impact factor: 2.125

3.  Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.

Authors:  Enrico Ammirati; Emanuele Bizzi; Giacomo Veronese; Matthieu Groh; Caroline M Van de Heyning; Jukka Lehtonen; Marc Pineton de Chambrun; Alberto Cereda; Chiara Picchi; Lucia Trotta; Javid J Moslehi; Antonio Brucato
Journal:  Front Med (Lausanne)       Date:  2022-03-07

Review 4.  Eosinophils from Physiology to Disease: A Comprehensive Review.

Authors:  Giuseppe A Ramirez; Mona-Rita Yacoub; Marco Ripa; Daniele Mannina; Adriana Cariddi; Nicoletta Saporiti; Fabio Ciceri; Antonella Castagna; Giselda Colombo; Lorenzo Dagna
Journal:  Biomed Res Int       Date:  2018-01-28       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.